Efficacy and safety of Epimedium total flavonoids for primary osteoporosis: a systematic review and meta-analysis

• Egile Nagusiak: Jinkun Li (Egilea), Xudong Huang (Egilea), Yifeng Yuan (Egilea), Haixin Zhang (Egilea), Hang Zhou (Egilea), Wei Xiong (Egilea), Yuyi Li (Egilea), Zechen Zhang (Egilea), Fengqing Qie (Egilea), Yingdelong Mao (Egilea), Bocheng Liang (Egilea), Xiaolin Shi (Egilea), Kang Liu (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2024-11-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

BackgroundEpimedium total flavonoids (EF) have been recommended to be one of the effective components in Traditional Chinese Medicine (TCM) for the treatment of primary osteoporosis (POP) in China. Due to the lack of evidence-based medical evidence on the efficacy and safety of EF for the treatment...